{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:07:06Z","timestamp":1779062826657,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47048-x","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:51:11Z","timestamp":1775026271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunometabolic determinants of hepatitis B vaccine seroprotection among Ethiopian adults"],"prefix":"10.1038","volume":"16","author":[{"given":"Adane","family":"Adugna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desalegn","family":"Abebaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baye","family":"Ashenef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gashaw Azanaw","family":"Amare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabarak","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenesew Mihret","family":"Wondmagegn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melkamu","family":"Tilahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Worku Abie","family":"Liyew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"47048_CR1","unstructured":"WHO. Global hepatitis report 2024: action for access in low- and middle-income countries, accessed on 2\/3\/2026. 9 April 2024."},{"issue":"12","key":"47048_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","volume":"2","author":"CW Spearman","year":"2017","unstructured":"Spearman, C. W. et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol. Hepatol. 2 (12), 900\u2013909 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"47048_CR3","unstructured":"CDC. https:\/\/africacdc.org\/disease\/hepatitis-b-virus-hbv\/, accessed on 8\/15\/2025."},{"key":"47048_CR4","doi-asserted-by":"crossref","unstructured":"Girmay, G. & Bewket, G. Seroprevalence of viral hepatitis B and C infections among healthcare workers in Ethiopia: A systematic review and meta-analysis. 19(11):e0312959. (2024).","DOI":"10.1371\/journal.pone.0312959"},{"issue":"2","key":"47048_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4149\/av_2018_210","volume":"62","author":"Y Qin","year":"2018","unstructured":"Qin, Y. & Liao, P. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV. Acta Virol. 62 (2), 115\u2013121 (2018).","journal-title":"Acta Virol."},{"key":"47048_CR6","unstructured":"MOH. https:\/\/www.moh.gov.et\/index.php\/Expanded_Program_on_Immunization, accessed on 2\/3\/2026."},{"issue":"1","key":"47048_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40545-022-00458-4","volume":"15","author":"D Tewuhibo","year":"2022","unstructured":"Tewuhibo, D., Asmamaw, G. & Ayenew, W. Cost-effectiveness analysis of current non-mandatory hepatitis B vaccination coverage vs expanding coverage among healthcare workers in Ethiopia. J. Pharm. Policy Pract. 15 (1), 65 (2022).","journal-title":"J. Pharm. Policy Pract."},{"key":"47048_CR8","doi-asserted-by":"crossref","unstructured":"Nettelfield, S. & Yu, D. Systemic immunometabolism and responses to vaccines: insights from T and B cell perspectives. 35(12):571\u2013582. (2023).","DOI":"10.1093\/intimm\/dxad021"},{"key":"47048_CR9","doi-asserted-by":"publisher","first-page":"27251","DOI":"10.1038\/srep27251","volume":"6","author":"S Yang","year":"2016","unstructured":"Yang, S. et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci. Rep. 6, 27251 (2016).","journal-title":"Sci. Rep."},{"key":"47048_CR10","doi-asserted-by":"crossref","unstructured":"Andersen, C. J. Lipid Metabolism in Inflammation and Immune Function. Nutrients 14(7). (2022).","DOI":"10.3390\/nu14071414"},{"key":"47048_CR11","doi-asserted-by":"crossref","unstructured":"Amodio, D. et al. Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference. Vaccine 43:126477. (2025).","DOI":"10.1016\/j.vaccine.2024.126477"},{"key":"47048_CR12","doi-asserted-by":"crossref","unstructured":"Zhao, H. et al. Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction. 19(12):1347\u20131360. (2022).","DOI":"10.1038\/s41423-022-00939-1"},{"key":"47048_CR13","doi-asserted-by":"publisher","first-page":"1369661","DOI":"10.3389\/fcimb.2024.1369661","volume":"14","author":"Q Yang","year":"2024","unstructured":"Yang, Q. et al. Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study. Front. Cell. Infect. Microbiol. 14, 1369661 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"47048_CR14","doi-asserted-by":"crossref","unstructured":"Garcia, C. & Andersen, C. J. The Role of Lipids in the Regulation of Immune Responses. 15(18). (2023).","DOI":"10.3390\/nu15183899"},{"issue":"6","key":"47048_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4103\/njcp.njcp_187_19","volume":"24","author":"BS Kwan","year":"2021","unstructured":"Kwan, B. S. et al. Immune response to hepatitis B vaccination and factors associated with poor immune response among healthcare workers. Niger. J. Clin. Pract. 24 (6), 795\u2013801 (2021).","journal-title":"Niger. J. Clin. Pract."},{"key":"47048_CR16","doi-asserted-by":"crossref","unstructured":"Hudu, S. A. & Jimoh, A. O. Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study. 2025:3879562. (2025).","DOI":"10.1155\/jotm\/3879562"},{"issue":"1","key":"47048_CR17","doi-asserted-by":"publisher","first-page":"27251","DOI":"10.1038\/srep27251","volume":"6","author":"S Yang","year":"2016","unstructured":"Yang, S. et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci. Rep. 6 (1), 27251 (2016).","journal-title":"Sci. Rep."},{"key":"47048_CR18","doi-asserted-by":"publisher","first-page":"1131373","DOI":"10.3389\/fmed.2023.1131373","volume":"10","author":"D Guo","year":"2023","unstructured":"Guo, D. et al. The relationship between triglyceride, cholesterol and lipoprotein levels, and immune responses to hepatitis B vaccine. Front. Med. 10, 1131373 (2023).","journal-title":"Front. Med."},{"key":"47048_CR19","doi-asserted-by":"publisher","first-page":"1480766","DOI":"10.3389\/fpubh.2025.1480766","volume":"13","author":"J Hu","year":"2025","unstructured":"Hu, J., Huang, K., Zou, H. & Li, J. Association between the systemic immune-inflammatory index and the immune response after hepatitis B vaccination: a cross-sectional analysis of NHANES data. Front. Public. Health. 13, 1480766 (2025).","journal-title":"Front. Public. Health"},{"key":"47048_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nutres.2017.02.001","volume":"41","author":"M Pae","year":"2017","unstructured":"Pae, M. & Wu, D. Nutritional modulation of age-related changes in the immune system and risk of infection. Nutr. Res. 41, 14\u201335 (2017).","journal-title":"Nutr. Res."},{"key":"47048_CR21","unstructured":"Center, N. V. I. https:\/\/www.nvic.org\/disease-vaccine\/hepatitis-b\/vaccine-effectiveness, accessed on 8\/30\/2025."},{"issue":"1","key":"47048_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/14760584.2023.2289566","volume":"23","author":"J Qiu","year":"2024","unstructured":"Qiu, J. et al. Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses. Expert Rev. Vaccines. 23 (1), 69\u201381 (2024).","journal-title":"Expert Rev. Vaccines"},{"issue":"8","key":"47048_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/14760584.2017.1338568","volume":"16","author":"C Van Den Ende","year":"2017","unstructured":"Van Den Ende, C., Marano, C., Van Ahee, A., Bunge, E. M. & De Moerlooze, L. The immunogenicity and safety of GSK\u2019s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Rev. Vaccines. 16 (8), 811\u2013832 (2017).","journal-title":"Expert Rev. Vaccines"},{"issue":"30","key":"47048_CR24","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3748\/wjg.v24.i30.3347","volume":"24","author":"IM Akcay","year":"2018","unstructured":"Akcay, I. M., Katrinli, S., Ozdil, K., Doganay, G. D. & Doganay, L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J. Gastroenterol. 24 (30), 3347\u20133360 (2018).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"47048_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/jiv750","volume":"214","author":"P Van Damme","year":"2016","unstructured":"Van Damme, P. Long-term Protection After Hepatitis B Vaccine. J. Infect. Dis. 214 (1), 1\u20133 (2016).","journal-title":"J. Infect. Dis."},{"issue":"8","key":"47048_CR26","doi-asserted-by":"publisher","first-page":"e0202637","DOI":"10.1371\/journal.pone.0202637","volume":"13","author":"N Posuwan","year":"2018","unstructured":"Posuwan, N. et al. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity. PloS one. 13 (8), e0202637 (2018).","journal-title":"PloS one"},{"issue":"28","key":"47048_CR27","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1016\/j.vaccine.2016.03.080","volume":"34","author":"AR Kolwaite","year":"2016","unstructured":"Kolwaite, A. R. et al. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR. Vaccine 34 (28), 3324\u20133330 (2016).","journal-title":"Vaccine"},{"key":"47048_CR28","doi-asserted-by":"crossref","unstructured":"Breakwell, L. et al. Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation. Vaccine 35(21):2770\u20132774 35(21). (2017).","DOI":"10.1016\/j.vaccine.2017.04.011"},{"issue":"5","key":"47048_CR29","doi-asserted-by":"publisher","first-page":"2053404","DOI":"10.1080\/21645515.2022.2053404","volume":"18","author":"E Min","year":"2022","unstructured":"Min, E., Min, J. & Kim, R. Age-specific seroprotection after Hepatitis B virus vaccination among Korean American pediatric population in Queens, New York. Hum. vaccines immunotherapeutics. 18 (5), 2053404 (2022).","journal-title":"Hum. vaccines immunotherapeutics"},{"issue":"8","key":"47048_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.vaccine.2020.12.050","volume":"39","author":"J Atsmon","year":"2021","unstructured":"Atsmon, J. et al. Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study. Vaccine 39 (8), 1328\u20131332 (2021).","journal-title":"Vaccine"},{"issue":"2","key":"47048_CR31","doi-asserted-by":"publisher","first-page":"e0281256","DOI":"10.1371\/journal.pone.0281256","volume":"18","author":"B Langat","year":"2023","unstructured":"Langat, B. et al. Sero-prevalence of hepatitis B virus and compliance with hepatitis B vaccination schedules among outpatient clinic attendees in Nairobi. PloS one. 18 (2), e0281256 (2023).","journal-title":"PloS one"},{"issue":"36","key":"47048_CR32","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1016\/j.vaccine.2021.07.017","volume":"39","author":"H Doi","year":"2021","unstructured":"Doi, H. & Kanto, T. Factors influencing the durability of hepatitis B vaccine responses. Vaccine 39 (36), 5224\u20135230 (2021).","journal-title":"Vaccine"},{"issue":"34","key":"47048_CR33","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.3748\/wjg.v20.i34.12018","volume":"20","author":"T Eleftheriadis","year":"2014","unstructured":"Eleftheriadis, T., Pissas, G., Antoniadi, G., Liakopoulos, V. & Stefanidis, I. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J. Gastroenterol. 20 (34), 12018\u201312025 (2014).","journal-title":"World J. Gastroenterol."},{"key":"47048_CR34","first-page":"20","volume":"33","author":"B Bijani","year":"2019","unstructured":"Bijani, B., Allami, A., Jafari, F., Hajmanoochehri, F. & Bijani, S. Long-term immunogenicity of hepatitis B vaccine and impact of a booster dose on health care. Med. J. Islamic Repub. Iran. 33, 20 (2019).","journal-title":"Med. J. Islamic Repub. Iran."},{"key":"47048_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12979-020-00179-9","volume":"17","author":"R Edelman","year":"2020","unstructured":"Edelman, R. et al. The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route. Immun. ageing: I A. 17, 9 (2020).","journal-title":"Immun. ageing: I A"},{"key":"47048_CR36","doi-asserted-by":"crossref","unstructured":"Trevisan, A. & Giuliani, A. Sex Disparity in Response to Hepatitis B Vaccine Related to the Age of Vaccination. 17(1). (2020).","DOI":"10.3390\/ijerph17010327"},{"key":"47048_CR37","first-page":"100605","volume":"22","author":"S Anticoli","year":"2025","unstructured":"Anticoli, S. et al. Sex differences in response to HBV vaccination in a cohort of health care workers. Vaccine: X. 22, 100605 (2025).","journal-title":"Vaccine: X"},{"issue":"2","key":"47048_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","volume":"41","author":"S Fischinger","year":"2019","unstructured":"Fischinger, S., Boudreau, C. M., Butler, A. L., Streeck, H. & Alter, G. Sex differences in vaccine-induced humoral immunity. Semin. Immunopathol. 41 (2), 239\u2013249 (2019).","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"47048_CR39","first-page":"103","volume":"20","author":"M Li","year":"2019","unstructured":"Li, M. et al. Contribution of sex\u2013based immunological differences to the enhanced immune response in female mice following vaccination with hepatitis B vaccine. Mol. Med. Rep. 20 (1), 103\u2013110 (2019).","journal-title":"Mol. Med. Rep."},{"key":"47048_CR40","doi-asserted-by":"crossref","unstructured":"Mironova, M. & Ghany, M. G. Hepatitis B Vaccine: Four Decades on. 12(4). (2024).","DOI":"10.3390\/vaccines12040439"},{"issue":"5","key":"47048_CR41","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/21645515.2016.1274475","volume":"13","author":"F Liu","year":"2017","unstructured":"Liu, F., Guo, Z. & Dong, C. Influences of obesity on the immunogenicity of Hepatitis B vaccine. Hum. vaccines immunotherapeutics. 13 (5), 1014\u20131017 (2017).","journal-title":"Hum. vaccines immunotherapeutics"},{"issue":"1","key":"47048_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41541-020-00266-4","volume":"6","author":"SS Joshi","year":"2021","unstructured":"Joshi, S. S. et al. Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD). npj Vaccines. 6 (1), 9 (2021).","journal-title":"npj Vaccines"},{"issue":"5","key":"47048_CR43","doi-asserted-by":"publisher","first-page":"102254","DOI":"10.1016\/j.dsx.2021.102254","volume":"15","author":"A Kabir","year":"2021","unstructured":"Kabir, A., Lotfi, S., Farsi, F. & Pazouki, A. Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study. Diabetes metabolic syndrome. 15 (5), 102254 (2021).","journal-title":"Diabetes metabolic syndrome"},{"issue":"4","key":"47048_CR44","first-page":"32","volume":"21","author":"RE Hodges","year":"2022","unstructured":"Hodges, R. E. & Lamotte, A. V. Impact of Diet and Lifestyle on Vaccine Efficacy in Adults Aged 55 and Older: A Review. Integr. Med. (Encinitas Calif). 21 (4), 32\u201352 (2022).","journal-title":"Integr. Med. (Encinitas Calif)"},{"key":"47048_CR45","doi-asserted-by":"crossref","unstructured":"Kashi, D. S. & Oliver, S. J. Vitamin D and the hepatitis B vaccine response: a prospective cohort study and a randomized, placebo-controlled oral vitamin D(3) and simulated sunlight supplementation trial in healthy adults. 60(1):475\u2013491. (2021).","DOI":"10.1007\/s00394-020-02261-w"},{"issue":"4","key":"47048_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000456596","volume":"35","author":"AA Jackson","year":"2017","unstructured":"Jackson, A. A. Nutrition and Liver Health. Dig. Dis. 35 (4), 411\u2013417 (2017).","journal-title":"Dig. Dis."},{"key":"47048_CR47","doi-asserted-by":"crossref","unstructured":"Li, Y. & Luo, G. Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection. 17(7):e1009722. (2021).","DOI":"10.1371\/journal.ppat.1009722"},{"key":"47048_CR48","doi-asserted-by":"publisher","first-page":"1015563","DOI":"10.3389\/fimmu.2022.1015563","volume":"13","author":"E Geerling","year":"2022","unstructured":"Geerling, E., Hameed, M., Weger-Lucarelli, J. & Pinto, A. K. Metabolic syndrome and aberrant immune responses to viral infection and vaccination: Insights from small animal models. Front. Immunol. 13, 1015563 (2022).","journal-title":"Front. Immunol."},{"key":"47048_CR49","doi-asserted-by":"crossref","unstructured":"Yang, Q. et al. Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study. Frontiers Cell. Infect. microbiology Volume 14\u20132024. (2024).","DOI":"10.3389\/fcimb.2024.1369661"},{"issue":"1","key":"47048_CR50","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/j.jinf.2022.04.015","volume":"85","author":"GL Salvagno","year":"2022","unstructured":"Salvagno, G. L., Henry, B. M., Pighi, L., De Nitto, S. & Lippi, G. Serum C reactive protein predicts humoral response after BNT162b2 booster administration. J. Infect. 85 (1), e24\u2013e25 (2022).","journal-title":"J. Infect."},{"key":"47048_CR51","doi-asserted-by":"crossref","unstructured":"Karabay, O. & Hamarat, K. F. The Association of Systemic Inflammatory Response with Hepatitis B Vaccine Unresponsiveness. 17(3). (2025).","DOI":"10.3390\/v17030338"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47048-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T23:43:04Z","timestamp":1779061384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47048"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47048-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study received formal approval from the Institutional Research Ethics Review Committee (IRERC) of College of Health Sciences, Debre Markos University, in strict adherence to the principles outlined in the Declaration of Helsinki, with approval code [R\/C\/S\/D\/317\/09\/2024].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was meticulously secured from each participant prior to their involvement in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"15310"}}